134 related articles for article (PubMed ID: 2174642)
1. Drug therapy for Helicobacter pylori infection: problems and pitfalls.
Glupczynski Y; Burette A
Am J Gastroenterol; 1990 Dec; 85(12):1545-51. PubMed ID: 2174642
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of anti-microbial agents and its clinical choice for H. pylori treatment].
Aoyama N; Shirasaka D; Sakai T; Shirakawa K
Nihon Rinsho; 1999 Jan; 57(1):43-52. PubMed ID: 10036934
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation.
Mégraud F; Occhialini A; Doermann HP
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():25-38. PubMed ID: 9440053
[TBL] [Abstract][Full Text] [Related]
4. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Helicobacter pylori.
Wolle K; Malfertheiner P
Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological therapy of Helicobacter pylori infection.
Hoffman JS
Semin Gastrointest Dis; 1997 Jul; 8(3):156-63. PubMed ID: 9232728
[TBL] [Abstract][Full Text] [Related]
7. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
8. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
[TBL] [Abstract][Full Text] [Related]
9. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of Helicobacter pylori infection: current status].
Wagner S; Gebel M; Manns M
Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
[TBL] [Abstract][Full Text] [Related]
11. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Moayyedi P; Ragunathan PL; Mapstone N; Axon AT; Tompkins DS
J Gastroenterol; 1998; 33 Suppl 10():62-5. PubMed ID: 9840021
[TBL] [Abstract][Full Text] [Related]
12. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
13. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to antibiotics used in Helicobacter pylori infection in children].
Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S
Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori.
Mégraud F
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S49-54. PubMed ID: 8574736
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Helicobacter pylori.
Bytzer P; O'Morain C
Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
[TBL] [Abstract][Full Text] [Related]
18. [How to treat after Helicobacter pylori eradication failure?].
Bruley des Varannes S
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):478-83. PubMed ID: 12700506
[TBL] [Abstract][Full Text] [Related]
19. [Clinico-pharmacologic considerations in Helicobacter pylori eradication therapy].
Leiss O; Von Bergmann K
Z Gastroenterol; 1993; 31(7-8):450-8. PubMed ID: 8379234
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori and peptic ulcer.
Korman MG; Tytgat GN
Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
